Abstract: The present invention discloses: (i) a non-pathogenic probiotic microorganism and its probiotic/therapeutic uses; (ii) a formulation comprising an aqueous solution of a volatile fraction (VF) prepared from the extract of at least one plant derived material and its therapeutic uses; (iii) a process of manufacturing the formulation from the plant derived material; (iv) a probiotic composition comprising the non-pathogenic probiotic microorganism of the invention and/or other probiotic microorganism(s) and the formulation of the invention, and its probiotic/therapeutic uses; (v) a composition for industrial applications comprising the formulation of the invention and microorganism(s) of industrial applicability; and (vi) industrial processes and apparatuses in which the latter composition is used.

Abstract: A method for the treatment of symptoms related to normal hormonal variations in women during fertile, peri- and post-menopausal age, by the administering of a composition comprising, as active ingredients, a water and/or fat-soluble cytosolic extract of pollen, optionally combined with Royal Jelly and Vitamin E.

Abstract: The present invention provides compositions comprising an essential oil, methods for preparing the compositions, and methods of disinfecting potable liquid with the compositions.

Abstract: Disclosed is a pharmaceutical composition including a therapeutic quantity of a COX-2 inhibitor having an IC50-WHMA COX-2/COX-1 ratio ranging from about 0.23 to about 3.33 with reduced gastrointestinal and cardiovascular toxicity. Also disclosed are methods for treating osteoarthritis, rheumatoid arthritis or acute pain with less side-effects and faster onset of action utilizing the disclosed pharmaceutical composition.

Abstract: A composition to provide a calming stress hormone regulating and immune stimulation effect, which includes a combination of linoleic and linolenic acids, within certain ratios; at least one flavenoid; and at least one component having calming properties.

Abstract: A health food/dietary supplement is disclosed, endowed with a protective action on liver function against exogenous and endogenous hepatoxic agents, the characterizing components of which are isovaleryl L-carnitine and/or propionyl L-carnitine and an extract of Silybum marianum (milk thistle) standardized to a least 70 percent by weight of silymarin.

Abstract: A synergistic insecticide is provided by the addition of sodium lauryl sulfate or lecithin to an essential oil, preferably an essential oil which has been deregulated by the Environmental Protection Agency, to enable independently inactive or relatively inactive materials to provide commercially acceptable insecticidal properties without the need for undesirable poisons that may be toxic to humans and pets.

Abstract: Methods of inhibiting the growth of organisms in aqueous systems such as papermaking systems, cooling systems and process waters of various types, comprises adding to the aqueous system a hop acid. Compositions comprising hop acids and papermaking suspensions or slurries, and/or additives, such as paper making additives, are also provided.

Abstract: The present invention discloses: (i) a non-pathogenic probiotic microorganism and its probiotic/therapeutic uses; (ii) a formulation comprising an aqueous solution of a volatile fraction (VF) prepared from the extract of at least one plant derived material and its therapeutic uses; (iii) a process of manufacturing the formulation from the plant derived material; (iv) a probiotic composition comprising the non-pathogenic probiotic microorganism of the invention and/or other probiotic microorganism(s) and the formulation of the invention, and its probiotic/therapeutic uses; (v) a composition for industrial applications comprising the formulation of the invention and microorganism(s) of industrial applicability; and (vi) industrial processes and apparatuses in which the latter composition is used.

Abstract: Sympathetic nerve-stimulating fragrant compositions with weight-loss effects, characterized by containing one or more selected from among fennel oil, grapefruit oil, pepper oil, hyssop oil, sage oil, estragon oil, eucalyptus oil, rosemary oil, cinnamon oil, clove oil, ylang ylang oil, ginger oil, geranium oil and olibanum, or one or more from among limonene, pinene, myrcene and benzyl benzoate as the active ingredients in the oils, and preferably also containing caffeine.

Abstract: A composition for use as cosmetic agent for enhancing breast growth and strengthening of the breast tissue comprises at least hop and ornithine. Fennel or a fennel derivative such as fennel leaf or fennel seed is preferably further added thereto. The composition can also be applied as medication for suppressing and preventing benign cysts. The composition can be manufactured in convenient tablet form and be made up wholly of natural constituents. Ingestion of the composition for a period of a few months will in most cases provide the first result.

Abstract: The present invention discloses: (i) a non-pathogenic probiotic microorganism and its probiotic/therapeutic uses; (ii) a formulation comprising an aqueous solution of a volatile fraction (VF) prepared from the extract of at least one plant derived material and its therapeutic uses; (iii) a process of manufacturing the formulation from the plant derived material; (iv) a probiotic composition comprising the non-pathogenic probiotic microorganism of the invention and/or other probiotic microorganism(s) and the formulation of the invention, and its probiotic/therapeutic uses; (v) a composition for industrial applications comprising the formulation of the invention and microorganism(s) of industrial applicability; and (vi) industrial processes and apparatuses in which the latter composition is used.

Abstract: A novel formulation is provided that serves to specifically inhibit the COX-2 mediated inflammatory response in animals. The formulation comprises comprising an effective amount of component I selected from the group consisting of alpha acids and beta acids and an effective amount of at least one component II selected from the group consisting of alpha acids, beta acids, essential oils, fats and waxes, with the proviso that component I and II are not the same compound. The composition provides specific inhibition of cyclooxygenase-2 with little or no effect on cyclooxygenase-1.

Abstract: Described here a composition comprising of alcoholic extracts of herbs RHIZOMA ZINGIBERIS RECENS, RHIZOMA PINELLIAE, FLOS CARTHAMI, RADIX REHMANNIAE, RADIX ANGELICAE SINESIS, RADIX PAENOIAE RUBRA, CACUMEN BIOTAE, SEMEN SESAMI NIGRUM, RADIX POLYGONI MULTIFLORI, FRUCTUS MORI combined with TINCTURE CAPSICUM, TINCTURE CANTHARIDINATE, and OLEUM RICINI for direct application to scalp for the treatment of all kinds of alopecia in humans. Alternately, the herbs listed here can be used individually.

Abstract: The Chilean Chilco plant, and extracts therefrom, is used to generate particular formulations having use medicinally as a diuretic, anti-pyretic and principally as a regulator of female menstruation. Other aspects of the invention include the use of Chilco extracts as enhancers of sexual function in both male and females.

Abstract: The invention provides a new formulation of the composition comprising Flos Lonicerae Fructus Forsythiae and Radix Scutellariae. This invention also provides a method for identification with HPLC and the characteristic peaks of the compositions of said composition. The composition possesses antiviral effective, namely, inhibition of influenza virus, parainfluenza virus, herpes I virus and herpes II virus. The invention refers to a method for preparation and control of the active components of Flos Lonicerae Fructus Forsythiae and Radix Scutellariae for its biological activity. The invention also provides a unique raw materials and intermediate formulation.

Abstract: The present invention relates to novel antiacne compositions containing extract of Krameria, or a pure compound from the extract, at least one of ximeninic acid or lauric acid, and an anti-inflammatory saponin extracted from Olax dissitiflora, Aesculus hippocastanum, Centella asiatica, Terminalia sericea, Glycyrrhiza glabra, or mixtures thereof.

Abstract: An antibacterial composition of matter comprising: (a) one or more hops acid or hops acid derivatives or hops resin or hops resin derivatives; and (b) one or more food grade surfactants, surface active agents, chelating agents, antioxidants, and/or organic acids is provided.

Abstract: A non-invasive and non-systemic method for administering a local anesthetic. The method comprises topical application of a local anesthetic in combination with an intradermal-penetration agent selected from the group consisting an aloe composition, a triglyceride, and a mixture thereof.

Abstract: There is provided a photostable and synergistically enhanced topical sunscreen composition. There is further provided a method of enhancing the photostability of a sunscreen active in a topical sunscreen composition. There is further still provided a method of synergistically enhancing the UV absorbance of a sunscreen active in a topical sunscreen composition. The preferred compositions and methods of the present invention use a dibenzoylmethane sunscreen active, an extract of Kaempferia Galanga, and a cosmetically acceptable vehicle.

Abstract: A Chinese herb medicine composition for a cancer prophylaxis and therapy includes Honeysuckle Flower, Mother Chrysanthemum Flower, Dandelion Herb, Viola Yedoensis and Semiaquilegia adosoides (DC) makino. The Chinese herb medicine composition is composed with a special ratio, and the special ratio of Honeysuckle Flower: Mother Chrysanthemum Flower: Dandelion Herb: Viola Yedoensis: Semiaquilegia adosoides (DC.) makino by weight is 1:1:1:1:1.

Abstract: Biological fouling is effectively controlled in water systems and process streams through the addition of hops extract.

Abstract: The Chilean Chilco plant, and extracts therefrom, is used to generate particular formulations having use medicinally as a diuretic, anti-pyretic and principally as a regulator of female menstruation. Other aspects of the invention include the use of Chilco extracts as enhancers of sexual function in both male and females.

Abstract: Disclosed is a pharmaceutical composition including a therapeutic quantity of an a joint restorative compound selected from aminosugars, chondroitin, collagen 2, or methyl sulfonyl methane; and a therapeutic quantity of a COX-2 inhibitor having an IC50-WHMA COX-2/COX-1 ratio ranging from about 0.23 to about 3.33.

Abstract: The utilization of at least one extract of a plant belonging to the cecropia genus as an active agent. The extract is used alone or in conjunction with at least one other active agent for preparing a cosmetic or dermopharmaceutical product or a cosmetic or dermopharmaceutical composition for external local application on the skin, the mucous membranes and/or the epithelial or body appendage formations.

Abstract: Antiviral and antifungal compositions comprise a ferrous salt and a plant extract of pomegranate rind, Viburnum plicatum leaves or flowers, tea leaves or maple leaves in aqueous solution.

Abstract: A method for the treatment of symptoms related to normal hormonal variations in women during fertile, peri- and post-menopausal age, by the administering of a composition comprising, as active ingredients, a water and/or fat-soluble cytosolic extract of pollen, optionally combined with Royal Jelly and Vitamin

Abstract: A fabric protectant comprising of a carrier and a plant oil selected from the group consisting of horseradish oil, bay oil, basil oil, calamus oil, ginger oil, palmarosa oil, cinnamon oil, ylang-ylang oil, perilla oil, valerian oil, clove oil, star anise oil, milfoil oil, fennel oil, oregano oil and angelica oil, efficaciously controls fabric-related pests. In addition, a method of protecting fabric which comprises dispersing, spraying, spreading and setting an effective amount of the plant oil selected from the group given above is an excellent method to control fabric-related pests.

Abstract: A process has been developed for production of a food flavoring compound maltol which comprises (a) extracting the dried and pulverized leaves of the plants belonging to the genus Abies with an alcohol at 20-40° C. and concentrating the solvent to obtain an alcoholic extract, (b) adsorbing the alcoholic extract with an adsorbent and drying the adsorbed material at a temperature ranging between 20-50° C., (d) partitioning of the adsorbed material between selected solvents consisting of aliphatic hydrocarbon and chlorinated solvent successively, (d) concentrating the chlorinated solvent to a residue and crystallizing it from a suitable organic solvent or mixtures of such solvents to get pure maltol.

Abstract: Biological fouling is effectively controlled in water systems and process streams through the addition of hops extract.

Abstract: The invention relates to a herbal skin care formulation comprising of beeswax, stearic acid, glycerol monostearate, olive oil, aloe gel, glycerine, triethanolamine, parabens, propylene glycol, essential oils, sandalwood oil, and the balance comprising rose water. The invention also relates to a process for the preparation of the formulation.

Abstract: A method for treating tinnitus comprising the step of administering to a subject requiring such treatment a therapeutically effective amount of an herbal composition comprising Radix Puerariae, Radix Platycodi Grandiflori, Radix Angelicae Dahuricae, Semen Coicis Lachryma-jobi, Rhizoma Zigiberis Officinalis Recens, Radix Ligustici Chuanxiong, Radix Paeoniae Lactiflorae, Folium Perillae Frutescentis, Flos Magnoliae, Herba cum Radice Asari, Ramulus Cinnamomi Cassiae, Radix Scutellariae Baicalensis, and Radix Glycyrrhizae Uralensis.

Abstract: Topical pharmaceutical compositions, containing as active ingredient a mixture of pollen extracts and vegetable oil unsaponifiables, useful for the treatment of cutaneous or circulatory pathologies on inflammatory, immune, proliferative or degenerative basis.

Abstract: This invention is directed to an Aromatherapy compound to combat symptoms of Premenstrual Syndrome. It uniquely comprises an externally applied compound consisting of “essential oils” (highly concentrated oils extracted from plant cells for use in natural, therapeutic applications) that aid in the relief or reduction of symptoms of PMS. The compound preferably comprises equal proportions of essential oil of geranium, essential oil of clary sage, and essential oil of orange. The compound can be used “neat” (directly on the skin), however, the preferred embodiment is to add the compound to a “carrier” (a base for diluting the Aromatherapy compound) such as lotion or vegetable oil. The preferred formula is approximately 3 milliliters essential oil (1milliliter of geranium, 1 milliliter of clary sage, and 1 milliliter of orange) blended in 120 milliliters of carrier.

Abstract: A method of treating nicotine addiction or deterring tobacco use in a subject by administering to the subject a therapeutically effective amount of Hypericum perforatum or at least one active component thereof is disclosed. As disclosed, the composition may further comprise a pharmaceutically acceptable carrier. The composition may also comprise a supplementary compound such as L-phenylalanine, L-tyrosine, tryptophan, 5-hydroxy tryptamine, serotonin, calcium carbonate and magnesium oxide, kava-kava, a kava alkaloid, valerian, hops, a passion flower extract, vitamin C, or Echinacea.

Abstract: The present invention relates to a process for making a flowable drug precursor product ready for pressing comprising humidifying dried plant drug material in a vacuum drying device together with the desired additives, carriers and/or excipients, which device comprises a multi-blade stirrer having its own drive and extending through a cylindrical mixing and drying chamber, said device optionally being provided with a filter, a back-purge means, a solvent condenser with an after-cooler and a collection vessel, a back-condenser and/or a process, control and regulation unit, and drying the humid mixture at a jacket temperature of the device of 20 to 50° C., a product temperature between 20 and 45° C. and a pressure of 20 to 500 mbar to obtain the precursor product, and also relates to said precursor products as such.

Abstract: Camomile oil having a high cis- and trans-spiroether content is produced in a process which includes steam distillation or aqueous distillation of fresh camomile or an extraction residue of camomile.

Abstract: The present invention relates to the discovery that hop extract is useful as an antibacterial agent against the dangerous pathogens Clostridium botulinum, Clostridium difficile, and Helicobacter pylori at levels below that at which a flavor from the acids contained therein is objectionable. More specifically, a process and associated product is described herein, comprising applying a solution of hop extract to a food, beverage or other medium so that the final concentration of hop ingredients is about 1 ppm or higher in order to inhibit the growth of Clostridium botulinum, Clostridium difficile, and/or Helicobacter pylori.

Abstract: A medicinal plant-derived antiviral powder is provided as obtained by collecting a medicinal plant having an antiviral action, immediately quickly heating the plant to de-activate enzymatic activity, subjecting to low temperature drying, and milling after the quick heating or low temperature. The powder may be extracted with hot water or a lower alcohol to obtain antiviral extract. These powder and extract may be utilized as preparations, particularly, a powder, comprising an effective amount thereof The powder and extract obtained by treating, as a medicinal plant, young leaves of Rhus verniciflua and a flower portion of Ulmus davidiana var.japonica are useful.

Abstract: The present invention relates to cosmetic formulations for topical application containing extracts from Phyllanthus emblica and Centella asiatica and/or Bacopa monnieri, and the use of such formulations for the care of the human skin. In particular, the present invention relates to cosmetic formulations for topical application containing extracts from Phyllanthus emblica and Centella asiatica and/or Bacopa monnieri in addition to per se known adjuvants and expedients.